Trifermed, a corporate strategy and business development firm in the health sector, and a CataloniaBio & HealthTech member, announced its expansion into North America. The company will open its headquarters in Boston, Massachusetts, and a representative office in Montreal, Canada. This expansion is a crucial part of trifermed’s strategy to extend its global influence in Biopharmaceuticals, MedTech, and Digital Health.
This strategic decision allows trifermed to provide more localized insights and connections, enhancing its service offerings to clients in this dynamic health ecosystem. The expansion into North America is a significant step in trifermed’s mission to bridge the gap between innovative ideas and market success. By establishing a presence in these key cities, trifermed strengthens its capability to support clients in bringing transformative healthcare solutions to a global audience.
“After extensive preparation and a series of successful initiatives, trifermed is poised to bring its unique expertise to the vibrant health innovation ecosystem of the United States,” said Prof. Sergi X. Trilla, MD, MBA · Founder,Chairman, & President. “Our new Boston hub will be instrumental in fostering closer connections within the heart of the industry and exemplifies our commitment to being where innovation thrives.”
Co-CEOs Ricardo and Daniel echoed this sentiment: “The synergy between our Barcelona team and the new U.S. operations is a blueprint for international success. We’re excited for the opportunities this will create for our clients and our team.”
The Barcelona base will continue as the operational backbone, supporting trifermed’s international endeavours, while the Boston presence will forge closer ties with industry stakeholders and foster innovation.
Comments